Last reviewed · How we verify

NCT07289659

Arthroscopic Repair of Partial Thickness Articular-Side Rotator Cuff Tears: Transtendon Versus Conversion Repair Techniques

Completed NA Last updated 17 December 2025
What this trial tests

NA trial testing Arthroscopic Conversion Repair in Partial Thickness Articular-Side Rotator Cuff Tears in 54 participants. Completed in 30 March 2023.

Timeline
1 October 2019
Primary endpoint
30 March 2023
30 March 2023

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment54
Start date1 October 2019
Primary completion30 March 2023
Estimated completion30 March 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

18 and older, any sex, with Partial Thickness Articular-Side Rotator Cuff Tears. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective randomized clinical trial compared two arthroscopic techniques for repairing partial-thickness articular-side rotator cuff tears: transtendon repair and conversion repair. Eligible patients with symptomatic tears exceeding 50% of tendon thickness, confirmed by MRI and intraoperative assessment, were randomly assigned to either repair technique. Functional outcomes, range of motion, complications, and MRI healing were assessed up to 24 months postoperatively

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07289659.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing